Sanofi Q1 beats est

Sanofi's first quarter earnings edges past estimates ahead of CEO change

Sanofi exceeded first-quarter earnings expectations with a 30.8% surge in Dupixent sales, while preparing for CEO Belén Garijo to take over in April after Paul Hudson's departure.